Introduction

Definition of long non-coding RNAs
There is no official consensus concerning the sequence or structural and biochemical features that might be used to clearly define long non-coding RNAs (lncRNAs). Nevertheless, transcripts that do not code for a protein and are longer than 200 nucleotides are usually considered to be lncRNAs (Pang et al., 2006; Cabili et al., 2011; Ulitsky et al., 2011; Derrien et al., 2012) . This size cut-off was arbitrarily chosen and is used to differentiate lncRNAs from smaller noncoding RNAs, such as microRNAs (miRNAs), small interfering RNAs (siRNAs), piwi-interacting RNAs (piRNAs), transfer RNAs (tRNAs) and small nucleolar RNAs (snoRNAs). Other non-coding, structural RNAs include ribosomal RNAs (rRNAs) and nuclear RNAs that are often longer than 200 nucleotides, but that are not considered to be lncRNAs (Taft et al., 2010; Morris and Mattick, 2014; Mattick and Rinn, 2015; Housman and Ulitsky, 2016) . Moreover, compared with protein-coding genes, lncRNA genes are usually shorter in length (Ulitsky et al., 2011; Derrien et al., 2012; Pauli et al., 2012) and have fewer exons (Ravasi, 2005; Zhu et al., 2009; Cabili et al., 2011; Derrien et al., 2012; Pauli et al., 2012) , although there are some exceptions. Finally, the assumption that lncRNAs are strictly noncoding transcripts was recently challenged by several groups who reported that some lncRNAs may encode short peptides with important functional roles (Ruiz-Orera et al., 2014) .
A brief history of the discovery of lncRNAs
The discovery of lncRNAs challenged one of the major biology dogmas. Indeed, in the common description of the human genome landscape, the~21 500 protein-coding genes (as indexed in Uniprot; Apweiler, 2004) are drowned in a vast ocean of repetitive and non-transcribed regions (Lander et al., 2001) . However, many tissue and cell transcriptome analyses provided evidence that in our genome also some non-coding DNA regions are transcribed into non-coding RNAs that may be functional. Consequently, a more complex definition of what is a gene is needed, because a seemingly silent zone of the genome can be transcribed, leading to the regulated production of non-coding RNAs, such as small regulatory RNAs or functional lncRNAs. Examples of functional lncRNAs are rapidly accumulating, proving their role in many mechanisms involved in cell regulation, signalling pathways, or cell identity in specific tissues or cell types.
Historically, the human genome has been roughly separated into coding and non-coding regions and only protein-coding genes and some structural non-coding RNAs, such as tRNAs and rRNAs, have been considered as essential for the cell functions. Most of the noncoding genome was thought to be junk DNA, without any noticeable function. RNA biology was dominated by the concept that gene transcription and translation are the main regulatory processes, thus positioning proteins as the key functional regulators (Morris and Mattick, 2014) . However, the roles ascribed to RNA have evolved along with technological developments. Messenger RNAs (mRNA) were discovered in the 1960s by Jacob, Meselson and Brenner. They showed that mRNAs are translated into proteins and have key functions within cells (Brenner et al., 1961) . In the 1970s, RNA expression in a specific cell or tissue could be studied only by Northern blot analysis, a complex and time-consuming procedure (Alwine et al., 1977) . The development of cloning methods and particularly of the PCR by Mullis in the 1980s allowed a better characterization of RNAs and their expression levels within specific tissues and cells (Mullis, 1990 ).
Meanwhile, other structural RNA classes were discovered, such as rRNAs, tRNAs and heteronuclear RNAs (hnRNAs) (Warner et al., 1966; Kim et al., 1974) . In the 1990s, the first cDNA arrays were developed, followed by tiling microarrays that can assess the expression of thousands of genes in a single experiment and even study gene expression genome-wide, outside protein-coding regions (Schena et al., 1995) . Microarrays revolutionized gene expression studies. For the first time, researchers did not have to know precisely what to look for to investigate gene expression in specific conditions, diseases or drug effects. These techniques were greatly informative to understand cell functionality, but initially they did not allow the detection of splicing variants, and most often relied on known protein-coding genes. While the international human genome sequencing programme was close to obtaining the first complete sequence, researchers were confronted with an unexpected difficulty. Indeed, they did not know how to differentiate untranslated genes from translated ones. It was thought that RNA maps could help in finding an answer to this issue. Improved sequencing technologies solved this problem. Several international research programmes, such as the Functional Annotation of the Mammalian Genome (FANTOM) project, using tiling microarray (Bertone et al., 2004) and sequencing techniques (Carninci et al., 2005) showed that most of the mammalian genome is actively transcribed into RNAs, although most of them do not code for proteins. Thousands of non-coding RNAs, including short (<200 nt) and long (>200 nt) RNAs, were identified. Furthermore, these projects showed that alternative splicing is very common, including in non-coding sections of the genome (Philippe et al., 2014) . These outcomes forced us to widen the definition of a gene and to consider that non-coding RNAs may not simply be junk DNA or transcriptional noise (ENCODE Project Consortium et al., 2007; Gerstein et al., 2007; Kapranov et al., 2007) . The advent of next generation sequencing (NGS) and the increasing accessibility to this technology because of falling costs enabled deep sequencing of the transcriptome (RNA-seq) of many cell/tissue types. Its rapid progress, as well as that of bioinformatics since the late 2000s, paved the way for truly understanding transcription on a genome-wide scale and in different conditions. Particularly, NGS offered the possibility to compare the expression pattern of coding and non-coding RNAs Mortazavi et al., 2008; Wang et al., 2009) .
All these techniques helped in describing and classifying non-coding RNAs in three subfamilies: small structural RNAs that include small nuclear RNAs involved in splicing regulation, snoRNAs involved in ribosome biogenesis, rRNAs and tRNAs involved in translation; small regulatory RNAs, such as miRNAs, piRNAs, snoRNAs that are involved in cell regulation; lncRNAs (Carninci et al., 2005; Mattick, 2006; Seto et al., 2007; Bartel, 2009; Rinn and Chang, 2012) . This class includes non-coding RNAs that present similarities with mRNAs in length, structure and transcriptional regulation. Indeed, many functional non-coding transcripts were studied before being designated as lncRNAs. They were simply considered to be large functional RNAs with no coding function Pandey et al., 2008) . The first described functional lncRNA was H19, discovered long before the advent of NGS and the first description of lncRNAs (Brannan et al., 1990) . H19 is abundantly expressed in many mesoderm-and endoderm-derived tissues and regulates a network of coexpressed imprinted genes that modulate foetal and post-natal growth (Gabory et al., 2010) . Indeed, H19 expression is regulated by genomic imprinting and is therefore expressed only by the maternal allele. Another lncRNA identified before their discovery is X-inactive specific transcript (XIST), which is transcribed only from the inactive X chromosome in mammalian female cells (Brown et al., 1991; Penny et al., 1996) . XIST is essential for X-inactivation and is pivotal for mammalian dosage compensation of the X chromosome (see below).
Here, we review the current knowledge on lncRNAs with a focus on their role in early human embryo development. Recent published mRNA sequencing (mRNA-seq) data indicate that in the early human embryo, as in other vertebrate embryos, lncRNA abundance significantly changes during each stage of development, suggesting key functional roles. Therefore, lncRNAs could represent novel candidate markers for the development of non-invasive tools to assess embryo competency.
Methods
Article selection
A summary of the general knowledge on lncRNAs was compiled based on seminal articles on this topic. A systematic review of the current literature in the English language on lncRNAs in mammalian, including human, early embryo development was performed. Articles were retrieved from journal databases, such as PubMed (http://www.ncbi. nlm.nih.gov/sites/entrez) and EMBASE (https://www.elsevier.com/ solutions/embase-biomedical-research) up to February 2016, using the keywords 'lncRNA', and 'embryo', 'development' or 'pluripotent stem cells (PSCs)'. A total of 2845 articles were retrieved of which 288 were included in this review.
RNA-sequencing data retrieval
Paired-or single-end RNA-seq data were downloaded from the NCBI SRA database (130 datasets corresponding to 5 SRA projects) (http:// www.ncbi.nlm.nih.gov/sra), or from the ENCODE project portal (36 datasets from 18 ENCODE projects) (https://www.encodeproject.org/). The maximum read length was 121 nt for the entire cohort and the minimum read length was 90 nt, but for 8 RNA-seq datasets from the PRJNA189204 human embryo Bioproject that had a minimum read length of 49 nt (Xue et al., 2013) . The dataset list is provided in Supplementary  Table S1 .
RNA-sequencing data analysis
Reads were mapped to the indexed Ensembl GRCh38 human genome using CRAC v2.5.0 (http://crac.gforge.inria.fr/) with a kmer parameter of 22 nt (-k 22) and the -bam option. Aligned reads were then counted against the Ensembl annotation file GRCh38.83 (Ensembl API version 66, http://www.ensembl.org/index.html) using featureCounts v14.6 with the default unstranded option (-s 0). RNA-seq data analysis focused on two Ensembl annotation categories: coding transcripts that included all protein-coding genes; and long non-coding transcripts that regrouped pseudogenes, sense and antisense overlapping transcripts, lncRNAs and lincRNAs. Small non-coding RNAs, such as miRNAs, were removed from the analysis, as well as rRNAs, which are not classified as lncRNAs.
Results and Discussion
LncRNA classification
Non-coding RNAs can be arbitrarily separated into two main classes according to their length: small (<200 nt) and long (>200 nt, i.e. lncRNAs) (Tuck and Tollervey, 2013; St. Laurent et al., 2015) . LncRNAs can then be further classified in two main subclasses according to their genome localization: intergenic and intragenic (Fig. 1A) . Currently, these lncRNA subclasses are not linked to a specific function or a mode of action. Moreover, no general mechanism of lncRNA biogenesis has been described so far, in contrast to small non-coding RNAs, such as piRNAs or miRNAs .
Intragenic lncRNAs
This lncRNA subclass can be further subdivided into several categories depending on the lncRNA position relative to the associated protein-coding gene (Marques et al., 2013) :
-Sense lncRNAs overlap with protein-coding regions and are transcribed from the same strand. Most of them do not encode proteins; however, several lncRNAs have both coding and non-coding potential. For instance, the intragenic lncRNA SRA (steroid receptor RNA activator) was among the first lncRNAs found to encode a small peptide (Chooniedass-Kothari et al., 2004; Kapranov et al., 2005; Denoeud et al., 2007; Djebali et al., 2008) .
-Antisense lncRNAs, usually called natural antisense transcripts (NATs), also overlap with protein-coding regions, but are transcribed from the opposite strand (Schwartz et al., 2008) . Sense and antisense lncRNAs can overlap with exonic or intronic regions or both. NATs exist in virtually every living species, including eukaryotes, prokaryotes and even viruses (Britto-Kido et al., 2013; Campbell et al., 2014) . However, no evolutionarily conserved NAT has been indexed He et al., 2008; Wahlestedt, 2013; Wood et al., 2013 ).
-Bidirectional lncRNAs in which the transcription start site is located less than 1 kb away from its neighbouring protein-coding gene. They are usually transcribed in the opposite direction (Knauss and Sun, 2013 ).
-Intronic lncRNAs are the predominant non-coding RNAs in the human genome and include totally intronic RNAs (TINs), which represent more than 70% of all non-coding RNAs (except rRNAs) in human cells (Nakaya et al., 2007) , and partially intronic RNAs (PINs), which are generally unspliced (Louro et al., 2009; St Laurent et al., 2012) .
Intergenic lncRNAs
Long intergenic (or intervening) lncRNAs, called lincRNAs, do not overlap with protein-coding regions (introns or exons). Therefore, their expression profile and the effects of their overexpression or down-regulation are simpler to interpret (Hangauer et al., 2013; Hacisuleyman et al., 2014) . Many functional lincRNAs display stability comparable to mRNAs (Clark et al., 2012) , active transcription marks such as the K4H36 chromatin signature at their promoter , and cell-specific expression profiles (Khalil et al., 2009; Jia et al., 2010) .
LincRNAs are not clearly evolutionarily conserved; however, a recent study identified more than 2500 lincRNAs that are expressed in three tetrapod species and originated 90 million years ago (Necsulea et al., 2014) . Most lincRNAs overlap with repetitive elements, such as short or long interspersed elements (SINEs or LINEs) (Ulitsky et al., 2011; Kelley and Rinn, 2012) , that seem to play significant roles within lincRNAs, notably by helping homologous base pairing with other RNAs (Gong and Maquat, 2011; Carrieri et al., 2012) .
This subclass includes also very long intergenic non-coding RNAs that are called vlincRNAs or macroRNAs. Their length can vary from 50 kb to 1 Mb and they can also derive from pseudogenes (St Laurent et al., 2013; Hackermüller et al., 2014; Milligan and Lipovich, 2014; Lazorthes et al., 2015) .
Mechanisms of action
Many lncRNAs are non-functional by-products of pervasive transcription (Struhl, 2007; Ebisuya et al., 2008; De Santa et al., 2010) . However, an increasing number of studies demonstrated that some lncRNAs have specific functions and that they can be major actors in the biology of a cell (Huarte and Marín-Béjar, 2015; Khorkova et al., 2015) .
LncRNA mechanisms of action are numerous due to their diverse structural conformations, biochemical properties and specific subcellular localization (Wang and Chang, 2011) . Most lncRNAs with documented functions have been found in the nucleus, but evidence of functional cytoplasmic lncRNAs is increasing. Nuclear lncRNAs are involved in many processes, including epigenetic, transcriptional, post-transcriptional and translational regulation mechanisms (Guttman and Rinn, 2012; Rinn and Chang, 2012; Ulitsky and Bartel, 2013) . On the other hand, cytoplasmic lncRNA functions are restricted essentially to post-transcriptional and translational regulation and they act through the modulation of mRNA stability and protein modifications (Rashid et al., 2016) . Their functions can be divided into five main categories (not mutually exclusive) that will be briefly described below and that are summarized in Fig. 1B . Examples illustrating these different mechanisms of action are given in Table I .
Molecular scaffolds
Most lncRNAs interact with DNA, RNA, proteins or a combination of these molecules. lncRNA tertiary structure leads to specific allosteric conformations, forming functional domains with high affinity for their targets (Guttman and Rinn, 2012) . These molecular scaffolds can bind to several cell components to form ribonucleoprotein complexes and guide their interaction partners towards specific genomic loci thanks to their RNA sequence (Tsai et al., 2010; Hacisuleyman et al., 2014; Quinn et al., 2014) . This type of mechanism highlights the importance of lncRNA structure and sequence for the formation, stability and localization of these complexes (Rouskin et al., 2013; Smith et al., 2013; Johnsson et al., 2014; Wan et al., 2014; He et al., 2015) .
Such scaffolding generally takes place in the nucleus, where lncRNAs form protein complexes that modulate transcription. Wellknown examples of proteins interacting with scaffolding lncRNAs include the chromatin modifiers PRC1 (Yap et al., 2010; Bonasio et al., 2014) , PRC2 (Polycomb Repressive Complex 2) and LSD1 (Lysine-specific histone demethylase 1) (Rinn et al., 2007) , the Trithorax Group (TrxG) of proteins (Rinn et al., 2007) , the DNMT (DNA methyltransferase) protein family (Martianov et al., 2007; Schmitz et al., 2010; Di Ruscio et al., 2013) LncRNAs can serve as adaptors by bringing together multiple components, such as proteins, RNAs or DNAs, to form ribonucleoprotein complexes (e.g. HOTAIR (Hox antisense intergenic RNA), ANRIL (Antisense non-coding RNA in the INK4 locus), MALAT1 (Metastasis associated lung adenocarcinoma transcript 1), TUG1 (Taurine up-regulated gene 1), NEAT1 (Nuclear paraspeckle assembly transcript 1)). 'Guide': via standard base pairing, lncRNAs can guide ribonucleoprotein complexes to a specific genomic location (e.g. HOTTIP (HOXA transcript at the distal tip), XIST (X specific inactive transcript), AIR (Antisense Igf2r RNA), KCNQ1ot1 (Kcnq1 opposite transcript 1), lincRNA-p21). 'Molecular decoy': lncRNAs can bind to protein complexes and prevent their interaction with their natural targets (e.g. GAS5 (Growth arrest specific 5), PANDA (P21 associated ncRNA DNA damage activated), NEAT1 (Nuclear paraspeckle assembly transcript 1)). 'miRNA sponge': ceRNAs (competing endogenous RNAs) can bind to and sequester miRNA, leading to the active transcription of their mRNA targets (e.g. MD1 (Myoblast Differentiation 1), H19, ROR (Regulator of Reprogramming)). 'Enhancer': eRNAs (enhancer RNAs) are derived from enhancer regions and regulate neighbouring gene expression in cis and trans, being often implicated in creating chromatin loops for stabilization and activation of the promoter region of their target gene (e.g. lncRNA-CSR (class switch recombination), HOTTIP (HOXA transcript at the distal tip)).
Long non-coding RNAs in early human embryo development Protein) and SRF (Serum response factor)), ribosomal complexes and also RNA polymerase II (Chisholm et al., 2012; West et al., 2014) . LncRNAs can recruit these proteins and directly bring them to gene regulatory regions, for example promoters, to activate transcription. They can also act as structural platforms to which several proteins can bind and form specific structural entities (Sunwoo et al., 2008) , such as nuclear speckles (MALAT1, Metastasis associated lung adenocarcinoma transcript 1) , paraspeckles (NEAT1/ MENβ, Nuclear Enriched Abundant Transcript 1) (Clemson et al., 2009; Murthy and Rangarajan, 2010; Souquere et al., 2010) and polycomb bodies (TUG1, Taurine Up-Regulated 1) (Yang, Lin, et al., 2011) .
Guides
The primary nucleotide sequence of lncRNAs recognizes specific genomic regions through direct DNA binding, while their secondary and tertiary structures allow the binding of cellular components. Therefore, they can guide specific proteins or assembled scaffolds to a specific target locus that these molecules could not reach on their own. Well-described examples are HOTAIR (HOX transcript antisense RNA) (Schorderet and Duboule, 2011) , AIR (Antisense Igf2r RNA) , KCNQ1OT1 (Kcnq1 opposite transcript 1) (Pandey et al., 2008) , lincRNA-p21 (Huarte et al., 2010) , HOTTIP (HOXA transcript at the distal tip) and XIST (Penny et al., 1996) .
Enhancers
Enhancer lncRNAs (eRNAs) operate on neighbouring genes (in cis) or over long distances (in trans) by binding to promoters and inducing their transcription activity (Ørom et al., 2010; Darrow and Chadwick, 2013; Fanucchi et al., 2013; Kaikkonen et al., 2013; Mousavi et al., 2013) . Many examples of eRNAs can be found in the literature (Han et al., 2007; Taft et al., 2009; De Santa et al., 2010; Kim et al., 2010; Lai et al., 2013; Lam et al., 2013; Melo et al., 2013; Ørom and Shiekhattar, 2013; Léveillé et al., 2015) . Most lncRNAs have an enhancer-like function in cis, as indicated by the finding that their depletion leads to decreased expression of neighbouring protein-coding genes (Ørom and Shiekhattar, 2013) . For instance, it has been shown that a lncRNA interacts with the Mediator transcriptional activator complex to regulate its chromatin localization and to increase its enzymatic activity (Lai et al., 2013) . Another eRNA facilitates the transition of paused RNA polymerase II into productive elongation by sequestering NELF, a negative elongation factor (Schaukowitch et al., 2014) .
Among the lncRNAs that act in trans, lncRNA-CSR (class switch recombination) is engaged in long-range RNA interactions that facilitate the chromosomal looping-mediated association with superenhancer regions (Pefanis et al., 2015) . HOTTIP is another longrange eRNA that drives HOX genes transcription by being in the proximity of its target genes via chromosomal looping . eRNAs are also involved in cancer progression, particularly in acute leukaemia (Trimarchi et al., 2014) and in colorectal cancer (McCleland et al., 2016) .
Decoys
Another way of regulating gene expression through lncRNAs is endogenous competition that takes place preferentially in the cytoplasm (Salmena et al., 2011; Tay et al., 2014) . Specifically, such lncRNAs act as molecular decoys by competitive binding to other cellular components, such as miRNAs, RNAs or proteins (transcription factors), in order to prevent their activity at their targeted action sites (Willingham et al., 2005; Hung et al., 2011; Wang et al., 2013; Johnsson et al., 2014) . These lncRNAs are called competing endogenous RNAs (ceRNAs). They can act as artificial miRNA 'sponges' that pair with and sequester miRNAs from their mRNA targets (Ebert et al., 2007) , as observed in plants and viruses (Franco-Zorrilla et al., 2007; Cazalla et al., 2010) . Of note, some of these miRNA sponges form remarkable structures termed circular RNAs (ENCODE Project Consortium et al., 2007; Hansen et al., 2013; Memczak et al., 2013; Guo et al., 2014) . The cytoplasmic lncRNA MD1 (Myoblast Differentiation 1) inhibits two important miRNAs (miR-133 and 135) and thus regulates myogenic progenitor cells during muscle differentiation (Cesana et al., 2011) . This competition mechanism is also involved in cancer (Karreth et al., 2011) . H19 is also found in the cytoplasm where it antagonizes let-7 miRNA subfamilies (Kallen et al., 2013) and is also a primary miRNA precursor that negatively regulates the expression of specific mRNAs Keniry et al., 2012) . Similarly, the ceRNA GAS5 (Growth arrest specific 5) targets the glucocorticoid receptor and prevents its binding to regulatory elements (Kino et al., 2010) . PANDA (P21 associated ncRNA DNA damage activated) is another cytoplasmic ceRNA that interacts with the transcription factor NF-Y to limit the expression of proapoptotic genes (Hung et al., 2011) . At the post-transcriptional level, lncRNAs with snoRNA ends interact with the FOX2 transcription factor to alter splicing patterns (Yin et al., 2012) , whereas the UVinduced lncRNA GADD7 (growth-arrested DNA damage-inducible gene 7) binds to the transcriptional repressor TDP-43 (TAR DNAbinding protein 43), leading to the degradation of CDK6 (Cyclindependent kinase 6) mRNA in the cytoplasm . NEAT1 can titrate specific mRNAs by sequestering them within nuclear paraspeckles from where they are not released for translation until NEAT1 is degraded or down-regulated (Chen and Carmichael, 2009) .
This titration mechanism of miRNAs should be effective only in specific cases because lncRNA level is generally lower than that of miRNAs and their mRNA targets (Bosson et al., 2014; Denzler et al., 2014) . Thus, lncRNA concentration within the cell has to exceed a certain level of expression to allow their role as miRNA sponges.
Controversy about lncRNA functional relevance
LncRNAs have also been called transcripts of unknown function (TUF) (Gingeras, 2007) or transcripts of unknown coding potential (TUCP) (Cabili et al., 2011) that are localized in transcriptionally active regions (Li et al., 2007) . Indeed, there are different views concerning lncRNA function. Although some lncRNAs, such as H19 or XIST, are now accepted as bona fide actors in cell regulation, the fraction of functional lncRNAs is still the subject of heated discussions (Kowalczyk et al., 2012) . One view is that most of the noncoding transcriptome results from spurious transcription and could even be just transcriptional noise (Ponjavic et al., 2007; Struhl, 2007 view is supported by the fact that many of these transcripts are expressed at very low levels (less than a single copy per cell for some lncRNAs) and seem to be less conserved than protein-coding RNAs (Ravasi, 2005; Schultes et al., 2005; Cabili et al., 2011) . However, pooling cells for transcriptome sequencing could dilute a potentially strong signal localized in only few cells within the overall population. Thus, some lncRNAs that show an overall low expression level could in fact be tremendously overexpressed in a limited number of cells. Alternatively, lncRNA expression could be limited to a specific time during development, or be transient to regulate a precise cell mechanism (Derrien et al., 2012; Palazzo and Gregory, 2014; Clark et al., 2015) .
Similarly, the lack of lncRNA conservation remains controversial. The absence of sequence conservation might suggest that lncRNAs do not have a key functional role (Ponjavic et al., 2007) ; however, lncRNAs may in fact be structurally conserved (Johnsson et al., 2014) . Analyses on the structural conservation of lncRNAs clearly support the hypothesis of an evolutionarily driven process Smith et al., 2013; Rands et al., 2014; Nitsche et al., 2015) . Moreover, the overall number of lncRNAs increases with the complexity of the organism (Taft et al., 2007) , an observation that could support lncRNA functionality (Mattick, 2004; Guttman et al., 2011) . Indeed, the list of annotated lncRNAs with proven function is steadily increasing, with roles in pathways as diverse as cell regulation, apoptosis, drug resistance, cell identity specification, pluripotency and many other processes (Altschul et al., 1990; Ponting et al., 2009; Pauli et al., 2011; Rinn and Chang, 2012; Ulitsky and Bartel, 2013; Huarte and Marín-Béjar, 2015; Khorkova et al., 2015) .
LncRNA expression in human pre-implantation embryos
LncRNAs and early embryo development
Cell lineage specification and differentiation during embryo development is achieved through the precise spatio-temporal activation of key genes in embryonic and progenitor cells (Ben-Tabou de- Leon and Davidson, 2007; Mallo and Alonso, 2013) . Some lncRNAs associated with embryonic development have been recently identified by RNA-seq of animal and human pre-implantation embryos (from pronuclear to blastocyst stage). In frog (Paranjpe et al., 2013) , mouse (Zhang, Huang, et al., 2014; Hamazaki et al., 2015) and bovine early embryos (Caballero et al., 2014) , maternal mRNAs peak in oocytes, whereas spliced lncRNAs are predominantly detected at the other early stages. Knockdown of some specific lncRNAs in bovine embryos affects embryo growth, resulting in increased developmental rates and larger blastocysts. In mice, siRNA-mediated silencing of a promoter-associated lncRNA specifically expressed in 2-cell stage embryos results in embryonic lethality. This phenotype is rescued by overexpressing the protein that interacts with this lncRNA (Hamazaki et al., 2015) . Importantly, all these studies highlight the huge number of lncRNAs expressed during embryo development.
Analysis of RNA-seq data of single cells from human preimplantation embryos and of human embryonic stem cells (hESCs) showed the expression of 3405 lncRNAs of which 2733 are potential novel intergenic non-coding RNAs. Interestingly, the expression of many of these lncRNAs is developmental-stage specific. Two other studies provided developmental-stage specific RNA-Seq data in human pre-implantation embryos (Xue et al., 2013; Blakeley et al., 2015) , but did not specifically analyse the lncRNA profiles during embryo development.
A strong lncRNA signature in pre-implantation human embryos
To illustrate the lncRNA expression profile of the first stages of human embryo development, we performed a meta-analysis of RNAseq expression data by assembling the expression profiles of the two studies that included all embryonic stages during the first week of development (Xue et al., 2013; Yan et al., 2013) including six human mature oocytes, three pronuclear embryos, five zygotes, eight 2-cell stage embryos, twenty 4-cell stage embryos, thirty-one 8-cell stage embryos, nineteen morulae and thirty late blastocysts, as well as ESCs, foetal and adult normal tissues, and cancer samples (Supplementary Table S1 ). The analysis of the proportion of lncRNA and protein-coding mRNA reads shows that lncRNAs are present from the beginning of human embryo development and become the predominant category of transcripts after embryonic gene activation (EGA) that occurs at the 4-cell to 8-cell stage ( Fig. 2A) .
Comparison with foetal RNA and adult tissues indicates that some of these lncRNAs are shared with foetal and adult tissues, while others are specific to early embryos (Fig. 2B) . On the other hand, some foetal/adult tissues display lncRNAs that are not present in the oocyte and early embryo samples. These findings indicate that early human embryos and differentiated cells (foetal/adult tissues) have quite distinct lncRNA profiles.
As some lncRNAs are detected at specific and crucial steps of early embryonic development, they could represent candidate markers of EGA and embryo competency. Taken together, these results support the notion that lncRNAs are part of the dynamic changes in transcript expression that occur during human early embryo development and that contribute to the dramatic morphological changes during development.
Re-expression of pre-implantation embryo lncRNAs in cancer
LncRNAs are involved in many essential physiological processes, from cell cycle control and apoptosis to epigenetic regulation. Therefore, deregulation of lncRNA expression could have dramatic consequences on cell homeostasis. Several lncRNAs exhibit oncogenic properties: HULC (Highly up-regulated in liver cancer RNA) (Du et al., 2012) and HEIH (Highly Expressed In Hepatocellular Carcinoma) in hepatocellular carcinoma ; HOTAIR in breast, gastric, colorectal and cervical cancer (Hajjari and Salavaty, 2015) ; MALAT1 in liver, pancreas, breast, colon and prostate carcinoma ; SRA in steroid-dependent tumours, such as breast and uterus cancer or ANRIL (Antisense Noncoding RNA In The INK4 Locus) in prostate cancers (Hauptman and Glavač, 2013) . Conversely, other lncRNAs have oncosuppressive features, such as MEG3 (Maternally Expressed Gene 3) in pituitary adenoma and meningioma, or lincRNA-p21, PTENP1 (PTEN Pseudogene 1) and GAS5 in prostate and breast cancer.
It has been proposed that some cancers arise through cell dedifferentiation towards more immature cell states or to a state reminiscent of PSCs (Ben-Porath et al., 2008; Schoenhals et al., 2009) . Therefore, we investigated whether selected lncRNAs that are up-regulated in pre-implantation embryos but not in adult tissue are reexpressed in three cancer types (lung, colon and bladder) using publicly available RNA-seq data. Our analysis indicates that AFAP1-AS1 (AFAP1 Antisense RNA 1) is present in lung cancer as well as in oocytes and up to the 8-cell embryo stage, but not in normal adult tissues (Fig. 2B) . AFAP1-AS1 has been reported to be overexpressed in several cancers, such as hepatocellular carcinoma , lung cancer (Zeng et al., 2016) and oesophageal squamous cell senting the proportion of lncRNAs and protein-coding genes at each stage of human early embryonic development. Embryonic genome activation (EGA) takes place at the 4 to 8-cell stage and is accompanied by a shift in the proportion of these three RNA categories. During and after EGA, lncRNAs become predominant over protein-coding genes. (B) Coverage plots of RNA-seq reads of selected lncRNA genes that are differentially expressed in early embryos and foetal/adult tissues, and in early embryos and cancer tissues. Emb: Embryo; Foe: foetal; Ad: adult. BCAR4 (Breast cancer anti-oestrogen resistance 4) is detected specifically during early development in pre-implantation embryos, PTENP1 (PTEN Pseudogene 1) in early embryos and also in foetal/adult tissues, while COLCA1 (Colorectal Cancer Associated 1) is expressed only in foetal/adult tissues. AFAP1-AS1 (AFAP1 antisense RNA 1), HOTAIR (Hox antisense intergenic RNA), AACSP1 (Acetoacetyl-CoA Synthetase Pseudogene 1), LUCAT1 (Lung Cancer Associated Transcript 1) are all expressed during embryo development and in cancer samples, whereas they are absent in foetal/adult tissues. carcinoma, even chemoresistant forms , and it is often associated with poor prognosis . Similarly, the oncogene HOTAIR is overexpressed in colon and bladder cancer and is detected also at the 8-cell embryo stage and morula, but not at the blastocyst stage. AACSP1 (Acetoacetyl-CoA Synthetase Pseudogene 1) is expressed in early embryos (oocyte to 8-cell stage) and then is reactivated in colon cancer. LUCAT1 (Lung Cancer Associated Transcript 1) is expressed at the blastocyst stage and upregulated in lung cancer compared with matched normal samples.
LncRNAs and PSCs
Pluripotency maintenance
Pluripotency is the capacity of a cell to differentiate into any of the body cell types (De Los Angeles et al., 2015) . For instance, hESCs can generate more than 200 specialized cell types that derive from the three primary germ layers (ectoderm, endoderm and mesoderm) (Ramirez, 2010) . Therefore, pluripotency maintenance and stem cell differentiation must be precisely regulated. Many transcriptions factors, such as OCT4 (Octamer-binding transcription factor 4) or the homeobox protein NANOG, chromatin modifiers and small noncoding RNAs form a complex network for pluripotency regulation (De Los Angeles et al., 2015) . Several recent studies showed that lncRNAs also are involved in this process (Guttman et al., 2011; Rosa and Brivanlou, 2013) . Indeed, lncRNAs have been described as 'regulators of regulators' or 'pivots of pluripotency' that maintain pluripotency or act as a barrier against differentiation (Huo and Zambidis, 2013; Jia et al., 2013) .
The first data that linked lncRNAs to ESC regulation were obtained in mice by microarray and Chip-seq experiments . They showed that mouse ESCs have specific lncRNA signatures that are lost during their differentiation. Guttman et al. (2010) discovered more than one thousand new lncRNAs in mouse ESCs. Many of these lncRNAs regulate and are regulated by pluripotency-associated transcription factors (Sheik Mohamed et al., 2010; Ng et al., 2012) . Moreover, knockdown of pluripotency-associated lncRNAs causes profound transcriptome variations in mouse ESCs (Guttman et al., 2011) , often resulting in loss of pluripotency and differentiation, as observed upon silencing of key pluripotency transcription factors (Sheik Mohamed et al., 2010) .
Like many other lncRNAs, pluripotency-associated lncRNAs act as scaffolds to guide epigenetic regulatory complexes (Mondal and Kanduri, 2012) that are required for transcriptional regulation in ESCs. These complexes include chromatin remodellers and histone modifiers, such as Polycomb and Tritorax complexes (Tsai et al., 2010) . For instance, the lincRNA TUNA (Tcl1 upstream neuronassociated) forms a complex with ribonucleoproteins and the nucleolar phosphoprotein Nucleolin to guide them to the Nanog, Sox2 (sex determining region Y) and Fgf4 (Fibroblast growth factor 4) promoters (Lin et al., 2014) . TUNA depletion decreases the expression level of these pluripotency factors and inhibits mouse ESC selfrenewal capacity and also differentiation into neural cells. Similarly, the lncRNAs ES1, ES2, ES3 are implicated in pluripotency and neural differentiation regulation in human cells (Ng et al., 2012) . The lncRNAs GOMAFU (also called MIAT, Myocardial infarction associated transcript) and AK141205 are direct targets of OCT4 and NANOG, respectively, and their depletion in mouse ESCs leads to important transcriptomic changes and pluripotency perturbation (Sheik Mohamed et al., 2010) .
Interestingly, many of these pluripotency-associated lncRNAs modulate the activity of epigenetic regulators. For instance, lncRNAs can regulate PRC2 function directly Kaneko et al., 2013; Dey et al., 2014) or indirectly through interaction with related cofactors, as is the case for the lncRNAs MEG3 or ANRIL (Shen et al., 2009; Yap et al., 2010; Kaneko et al., 2014) . LncRNAs also interact with Tritorax-related factors, such as WDR5 (WD repeat-containing protein 5) that is very active in ESCs and regulates transcription by promoting H3K4me3 deposition. Notably, lincRNA-1592 and lincRNA-1552 regulate and are regulated by pluripotency transcription factors in a positive feedback loop . RoR (Regulator of reprogramming) is another important lncRNA for the maintenance of hESC self-renewal capacity. This lncRNA acts as a ceRNA in the cytoplasm where it maintains pluripotency by endogenous competition (Wang et al., 2013 ) with miR-145, which normally inhibits translation of pluripotency transcription factors (Xu et al., 2009 ).
Pluripotency induction
Induced PSCs (iPSCs) are PSCs generated directly from adult somatic cells, such as fibroblasts, by overexpressing four specific transcription factors that reprogram adult cells into PSCs (Takahashi et al., 2007) . Loewer et al. found that some lncRNAs are up-regulated in iPSCs compared with ESCs (Loewer et al., 2010) . However, it is not clear whether this difference is linked to intrinsic differences between iPSCs and ESCs, or to distinct features of their reprograming protocol. Importantly, the lncRNA RoR is essential for cell reprogramming. Indeed, its depletion by shRNA-mediated knockdown leads to an important decrease of iPSC colonies, while its overexpression promotes iPSC colony formation. Specifically, RoR depletion causes p53 up-regulation , leading to induction of apoptosis and oxidative stress, and ultimately to cell reprogramming defects. Pluripotency is regulated also by linc-p21, another lncRNA that represses p53 (Huarte et al., 2010; Bao et al., 2015) . Differently from RoR, linc-p21 reduces reprogramming efficiency by acting on the conversion from pre-iPSCs to iPSCs that is required to establish bona fide PSCs and during which the presence of the exogenous reprogramming factors is no longer needed (Hanna et al., 2010) . Linc-p21 forms a complex with HNRNPK (ribonucleoprotein heterogeneous nuclear ribonucleoprotein K) that maintains repressive H3K9me3 marks and CpG methylation at the promoter of core pluripotency transcription factors. Interestingly, linc-p21 is also found in the cytoplasm where it acts as a post-transcriptional modulator by repressing the translation of beta catenin and JUNB mRNAs by imperfect base pairing, forming a complex that enhances the interaction between mRNAs and cytoplasmic translational repressors (Rashid et al., 2016) .
Regulation of genomic imprinting by lncRNAs
Genomic imprinting is a crucial developmental epigenetic process that results in the mono-allelic expression of certain genes, in a parent-of-origin dependent manner (for a general review on this phenomenon; Barlow and Bartolomei, 2014) . These genes are thus called imprinted genes. Currently, about 100 imprinted genes have been identified. Many of them are essential for embryo development and growth (especially during gestation and post-partum) and genetic mutations at imprinted regions can cause various pathologies, particularly growth disorders (Azzi et al., 2014) and cancers (Kim et al., 2015) . Most imprinted genes are grouped in large clusters with coordinated expression (Abramowitz and Bartolomei, 2012) . It has been hypothesized that the regulation of these clusters is directed by lncRNAs that operate locally in cis by interacting with chromatin modifiers, or in trans by controlling gene expression (Autuoro et al., 2014; Kanduri, 2016) . Moreover, many imprinted genes have features in common with lncRNAs, for example their tissue and temporal specific expression, suggesting that they could be regulated by lncRNAs, or that they share similar regulating mechanisms in differentiated tissues (Prickett and Oakey, 2012) .
KCNQ1OT1 is a lncRNA that is transcribed in the opposite direction to the protein-coding gene KCNQ1 (potassium voltage-gated channel, KQT-like subfamily, member 1). KCNQ1 can be silenced by KCNQ1OT1 (Thakur et al., 2004; Kanduri, 2011) . This lncRNA is expressed only from the paternal allele (Khoueiry et al., 2008) and contributes to the repression of transcription of at least four neighbouring genes via interaction with chromatin modifiers, such as the PRC2 complex , and with histone-modifying enzymes, such as histone methyltransferases and deacetylases (Otte and Kwaks, 2003) . Mouse Air (Sleutels et al., 2002) (or Airn for Antisense Igf2r RNA Noncoding) shares some characteristics with KCNQ1OT1. It is expressed only from the paternal allele and its expression silences neighbouring protein-coding genes present on the maternal Igf2r (insulin-like growth factor 2 receptor) locus. Igf2r is expressed from the maternal chromosome (Barlow and Bartolomei, 2014) , but can be repressed by Air by limiting RNA polymerase II access to the Igf2r promoter. An orthologue of Air, named AIR, was found in human cells, but its function is unknown because IGF2R is expressed by both paternal and maternal alleles in humans (Yotova et al., 2008) . H19 is a maternally expressed lncRNA (Brannan et al., 1990) that acts in conjunction with the protein-coding IGF2 gene that is expressed from the paternal allele (Smits et al., 2008) . H19 is involved in the regulation of foetal growth (Gabory et al., 2010) by limiting body weight increase, whereas IGF does the opposite. It also acts as an oncogene in various cancer types (Matouk et al., 2007) and is deregulated in many growth disorders (Wojdacz et al., 2008) .
Mouse orthologues of these lncRNAs have been identified, suggesting an important functional and evolutionarily conserved role. Finally, it must be noted that deregulation of these lncRNAs leads to various forms of cancer (Higashimoto et al., 2006; and are therefore considered as new targets for drugs (Fatemi et al., 2014) .
X chromosome inactivation
Human female cells possess two X chromosomes, whereas male cells possess one X and one Y. In female cells, the overexpression of Xlinked genes is inhibited via a dosage compensation mechanism, called X chromosome inactivation (XCI) (Gartler et al., 1992) . XCI leads to the random silencing of one of the two X copies (either maternal or paternal), after embryo implantation in the uterus wall. Once silenced, the same inactive X chromosome is transmitted to all daughter cells. XCI is a well-studied mechanism that helped in highlighting the functional role of the mammalian lncRNA XIST (Brockdorff et al., 1992; Penny et al., 1996) . A specific locus on the X chromosome contains several lncRNAs among which is XIST, which is a 19 kb transcript, and XIST antisense transcript (TSIX), which is 40 kb-long and negatively regulates XIST (Stavropoulos et al., 2001) . The mechanism whereby XIST transcription is promoted at the future inactivated X chromosome copy (Xi) while TSIX transcription is promoted at the future active X chromosome (Xa) is unknown. XIST transcripts form a coat around the Xi and promote the recruitment of chromatin remodellers, such as PRC2 (Lee, 2012 ) that deposits inactive chromatin marks. Another recently identified lncRNA, XACT (X-Active Coating Transcript), might coat the Xa to protect it from inactivation (Vallot et al., 2013) . XACT is a very long transcript (252 kb) that is only expressed on the Xa and only in PSCs.
Regulation of developmental gene expression
Beside early embryonic development, lncRNAs have also been involved in the subsequent steps of embryonic and foetal development, ranging from the regulation of HOX genes via the lncRNA HOTAIR (Rinn et al., 2007) to cell differentiation (Fatica and Bozzoni, 2014) . For instance, modulation of the expression of brain-specific lncRNAs affects the differentiation capacity of neural progenitors. MALAT1 dysregulation influences synapse density and dendrite growth (Bernard et al., 2010) by controlling the localization of key neuronal transcription factors, while BDNF-AS (Brain-derived neurotrophic factor antisense) controls neurite formation (Modarresi et al., 2012) . Forced overexpression of the lncRNA NKX2.2AS (NK2 Homeobox 2 antisense) (Tochitani and Hayashizaki, 2008) in neural stem cells induces differentiation of oligodendrocytes. LncRNAs are also involved in heart development. The mouse-specific lncRNA Bvht (Braveheart) controls differentiation of mesodermal precursors into cardiomyocytes by regulating the expression of MesP1 (mesoderm posterior basic helix-loop-helix transcription factor 1) through its interaction with the PRC2 histone modifier (Klattenhoff et al., 2013) . Bvht is required for proper development of cardiomyocytes because its depletion affects the expression of cardiac-specific genes and prevents cardiomyocyte maturation. Table II lists other examples illustrating the major contribution of lncRNAs in gene expression regulation during mammalian development.
Potential applicability of lncRNAs for noninvasive testing of oocyte/embryo quality ART includes the selection of the embryos with the best developmental potential before their transfer into the uterus. Currently, the method of choice to evaluate embryo quality is based on the microscopic observations of various morphological parameters (Lundin et al., 2001; Racowsky et al., 2010) . However, morphological criteria might be insufficient for predicting embryo quality and pregnancy outcome (Assou et al., 2011; Mastenbroek et al., 2011) and adjunctive technologies for the assessment of embryo potential are currently investigated (Hillier, 2008 
Mouse
Foregut and lung endoderm Maturation of human embryonic lungs Herriges et al. (2014) identification of molecular biomarkers based on analysis of the oocyte microenvironment (specifically cumulus cells) using sophisticated and high-performance technologies, such as quantitative RT-PCR, microarray and RNA sequencing. Several groups have proposed using mRNAs expressed in cumulus cells as a non-invasive biomarker to predict oocyte quality and embryo competence and/or pregnancy outcome (McKenzie et al., 2004; Assou et al., 2008 Assou et al., , 2010 Anderson et al., 2009; Assidi et al., 2011; Gebhardt et al., 2011; Fragouli et al., 2012) . Other groups investigated the role of miRNAs in cumulus cells and tried to link their expression profile in cumulus cells with oocyte maturation and polycystic ovary syndrome (PCOS) (Assou et al., 2013; Tong et al., 2014; Liu et al., 2015; Huang, Liu, et al., 2016) . Similarly, the lncRNA expression profile might not only reflect the developmental stage of the embryo but also that of granulosa and cumulus cells (Burnik Papler et al., 2015) . Indeed, differential cumulus cell expression of specific lncRNAs was reported in germinal vesicle and mature (metaphase II) oocytes (Yerushalmi et al., 2014) and in preimplantation embryos of high and poor quality (Xu et al., 2015) . Moreover, lncRNAs are aberrantly expressed in cumulus cells of patients with PCOS compared to women without PCOS, suggesting that lncRNA expression may influence oocyte competence . Thus, as for mRNAs and miRNAs, the analysis of lncRNAs expressed in cumulus cells using quantitative RT-PCR might also be used for the development of a non-invasive test for the selection of oocytes to be fertilized and/or of good-quality embryos for transfer during IVF procedures. Further studies are required to validate the suitability and value of cumulus cell lncRNA expression testing in ART. Moreover, as the expression patterns of lncRNAs in preimplantation embryos suggest a potential role of lncRNAs during human early embryonic development, specific embryonic lncRNAs released into the culture medium after IVF are potentially attractive biomarkers for the prediction of embryo quality and pregnancy outcomes.
Conclusion
LncRNAs are a group of recently identified RNA molecules involved in many important biological processes in virtually all life forms. The total number of lncRNAs is still unknown, but is steadily increasing and has already surpassed that of protein-coding genes. They have been recognized as major regulators of mammalian tissue physiology and disease processes, including cancer. Moreover, lncRNAs are strongly expressed in the early human embryo, with a rapidly changing expression pattern, and some of them contribute to critical aspects of early human development. These lines of evidence show that lncRNAs are still widely unexplored in early human development and strongly suggest that they may become a means of intervention in ART.
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